文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

用于粪便微生物群移植的厌氧粪便处理可提高专性厌氧菌的活力。

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes.

作者信息

Bénard Mèlanie V, Arretxe Iñaki, Wortelboer Koen, Harmsen Hermie J M, Davids Mark, de Bruijn Clara M A, Benninga Marc A, Hugenholtz Floor, Herrema Hilde, Ponsioen Cyriel Y

机构信息

Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

出版信息

Microorganisms. 2023 Sep 5;11(9):2238. doi: 10.3390/microorganisms11092238.


DOI:10.3390/microorganisms11092238
PMID:37764082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10535047/
Abstract

Fecal microbiota transplantation (FMT) is under investigation for several indications, including ulcerative colitis (UC). The clinical success of FMT depends partly on the engraftment of viable bacteria. Because the vast majority of human gut microbiota consists of anaerobes, the currently used aerobic processing protocols of donor stool may diminish the bacterial viability of transplanted material. This study assessed the effect of four processing techniques for donor stool (i.e., anaerobic and aerobic, both direct processing and after temporary cool storage) on bacterial viability. By combining anaerobic culturing on customized media for anaerobes with 16S rRNA sequencing, we could successfully culture and identify the majority of the bacteria present in raw fecal suspensions. We show that direct anaerobic processing of donor stool is superior to aerobic processing conditions for preserving the bacterial viability of obligate anaerobes and butyrate-producing bacteria related to the clinical response to FMT in ulcerative colitis patients, including , , and . The effect of oxygen exposure during stool processing decreased when the samples were stored long-term. Our results confirm the importance of sample conditioning to preserve the bacterial viability of oxygen-sensitive gut bacteria. Anaerobic processing of donor stool may lead to increased clinical success of FMT, which should further be investigated in clinical trials.

摘要

粪便微生物群移植(FMT)正在针对多种适应症进行研究,包括溃疡性结肠炎(UC)。FMT的临床成功部分取决于活细菌的植入。由于绝大多数人类肠道微生物群由厌氧菌组成,目前使用的供体粪便需氧处理方案可能会降低移植材料的细菌活力。本研究评估了供体粪便的四种处理技术(即厌氧和需氧,包括直接处理和临时冷藏后处理)对细菌活力的影响。通过将定制的厌氧菌培养基上的厌氧培养与16S rRNA测序相结合,我们能够成功培养并鉴定出原始粪便悬液中存在的大多数细菌。我们表明,对于保存与溃疡性结肠炎患者FMT临床反应相关的专性厌氧菌和产丁酸细菌的细菌活力,供体粪便的直接厌氧处理优于需氧处理条件,包括[具体细菌名称1]、[具体细菌名称2]和[具体细菌名称3]。当样本长期储存时,粪便处理过程中氧气暴露的影响会降低。我们的结果证实了样本处理对于保存对氧敏感的肠道细菌的细菌活力的重要性。供体粪便的厌氧处理可能会提高FMT的临床成功率,这一点应在临床试验中进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/77f1ea2afb60/microorganisms-11-02238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/f6487ce6d93f/microorganisms-11-02238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/571fae960e02/microorganisms-11-02238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/77f1ea2afb60/microorganisms-11-02238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/f6487ce6d93f/microorganisms-11-02238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/571fae960e02/microorganisms-11-02238-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07b3/10535047/2dafb302e795/microorganisms-11-02238-g004.jpg

相似文献

[1]
Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes.

Microorganisms. 2023-9-5

[2]
Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.

BMC Microbiol. 2021-10-9

[3]
A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process.

Microbiol Spectr. 2023-2-14

[4]
Shifts and importance of viable bacteria in treatment of DSS-induced ulcerative colitis mice with FMT.

Front Cell Infect Microbiol. 2023

[5]
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.

Gastroenterology. 2018-12-6

[6]
Cross-Talk Between Butyric Acid and Gut Microbiota in Ulcerative Colitis Following Fecal Microbiota Transplantation.

Front Microbiol. 2021-4-12

[7]
Bacterial viability in faecal transplants: Which bacteria survive?

EBioMedicine. 2019-2-19

[8]
Evaluation of Bacterial Viability for Fecal Microbiota Transplantation: Impact of Thawing Temperature and Storage Time.

Microorganisms. 2024-6-25

[9]
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.

PLoS One. 2018-1-31

[10]
Effects of Different Treatment of Fecal Microbiota Transplantation Techniques on Treatment of Ulcerative Colitis in Rats.

Front Microbiol. 2021-7-14

引用本文的文献

[1]
Stunting is associated with persistent and transferable alterations in the gut microbiome.

Gut Pathog. 2025-6-25

[2]
Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol.

BMJ Open. 2025-4-19

[3]
Impact of Fecal Microbiota Transplant Formulations, Storage Conditions, and Duration on Bacterial Viability, Functionality, and Clinical Outcomes in Patients with Recurrent Infection.

Microorganisms. 2025-3-4

[4]
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights.

Gut Microbes. 2025-12

[5]
In vitro validation concept for lyophilized fecal microbiota products with a focus on bacterial viability.

World J Microbiol Biotechnol. 2025-2-27

[6]
Multi-Omics Analysis Unravels the Impact of Stool Sample Logistics on Metabolites and Microbial Composition.

Microorganisms. 2024-9-30

[7]
Evaluating Bacterial Viability in Faecal Microbiota Transplantation: A Comparative Analysis of In Vitro Cultivation and Membrane Integrity Methods.

J Clin Lab Anal. 2024-10

[8]
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments.

Microbiome. 2024-7-1

[9]
Fecal microbiota transplantation: current challenges and future landscapes.

Clin Microbiol Rev. 2024-6-13

[10]
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.

Indian J Gastroenterol. 2024-2

本文引用的文献

[1]
Challenges and costs of donor screening for fecal microbiota transplantations.

PLoS One. 2022

[2]
Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.

Clin Gastroenterol Hepatol. 2023-5

[3]
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.

Nat Med. 2022-9

[4]
Drivers and determinants of strain dynamics following fecal microbiota transplantation.

Nat Med. 2022-9

[5]
Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial.

Gut. 2022-12

[6]
Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis.

EBioMedicine. 2022-7

[7]
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.

Lancet Gastroenterol Hepatol. 2022-2

[8]
Stool preparation under anaerobic conditions contributes to retention of obligate anaerobes: potential improvement for fecal microbiota transplantation.

BMC Microbiol. 2021-10-9

[9]
When anaerobes encounter oxygen: mechanisms of oxygen toxicity, tolerance and defence.

Nat Rev Microbiol. 2021-12

[10]
Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future?

Cell Metab. 2021-6-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索